Poland· PL-100114433
Dexadent
A other agents for local oral treatment product containing dexamethasoni acetas + framycetini sulfas + polymyxini b sulfas, registered in Poland by Chema-Elektromet Spółdzielnia Pracy. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamethasoni acetas + framycetini sulfas + polymyxini b sulfas is registered in 2 of 19 countries.
Countries holding a registration under ATC A01AD (other agents for local oral treatment), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Dexamethasoni acetas + framycetini sulfas + polymyxini b sulfas · ATC A01AD
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Dexamethasoni acetas + Framycetini sulfas + Polymyxini B sulfas
- Manufacturer
- Chema-Elektromet Spółdzielnia Pracy
- Country
- Poland (PL)
- ATC code
- A01AD
- ATC class
- Other agents for local oral treatment
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991001919
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethasoni acetas + framycetini sulfas + polymyxini b sulfas in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32811558-8a18-47f8-8ef7-3b1c15b3609a GET /v1/drugs/32811558-8a18-47f8-8ef7-3b1c15b3609a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(10 mg + 25 mg + 2,5 mg)/g",
"packaging": "05909991001919 ¦ Rp ¦ 20826\n1 op. 5 g",
"substance": "Dexamethasoni acetas 10 mg/g + Framycetini sulfas 25 mg/g + Polymyxini B sulfas 2.5 mg/g",
"common_name": "Dexamethasoni acetas + Framycetini sulfas + Polymyxini B sulfas",
"pl_product_id": "100114433",
"pozwolenie_nr": "10019",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about dexamethasoni acetas + framycetini sulfas + polymyxini b sulfas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.